- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts1 new
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
TMO Market Currents
more »
-
Thursday 1:51 PM Cowen says Thermo Fisher's (TMO +1.6%) current valuation represents a primo buying opportunity . The firm says its risk/reward profile is even more attractive following its analyst day, citing expectations for improved earnings growth, increased market share, and management's belief shares are undervalued.
1 Comment[Healthcare, On the Move]
TMO in Focus
more »
TMO Related Articles
more »
TMO News
more »
-
at CNBC.com (Apr 30, 2012)
-
at MarketWatch.com (Apr 25, 2012)
-
at MarketWatch.com (Apr 24, 2012)
-
at MarketWatch.com (Apr 21, 2012)
-
at MarketWatch.com (Mar 21, 2012)
TMO Press Releases and Filings
more »
-
Business Wire (Thu, 9:00AM)
-
Business Wire (Mon, 8:00AM)
-
Business Wire (May 9, 2012)
-
Business Wire (May 1, 2012)
-
Business Wire (Apr 25, 2012)
TMO Latest Transcript
more »
-
Wed, May 23Popular searches: M&A.
TMO Cramer
more »
-
Tue, Feb 23, 2010
-
Sun, Jan 24, 2010
-
Sun, Dec 14, 2008
TMO Instablog posts
more »
TMO vs. ETF Alternatives
Company Description
Thermo Fisher Scientific Inc. (also referred to in this document as “Thermo Fisher,” “we,” the “company,” or the “registrant”) is the world leader in serving science. We enable our customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents... More
